TECLens, Inc., a clinical-stage ophthalmic medical device company, announced today it raised $9.3 million in a Series A round co-led by Johnson & Johnson Innovation – JJDC Inc. and Yonjin Capital.

The Blackhawks and Capitals lead the way with seven ranked prospects apiece, followed by the Sharks, Wild and Predators with ...

Ever since COVID-19 restrictions began to fade away, travel has boomed. In fact, as of the first nine months of 2024, global ...